Call Pharmacy +91 90310 13315
H

Arbitel-Trio 25 Tablet ER

Telmisartan (40mg) + Cilnidipine (10mg) + Metoprolol (25mg)

₹118.00


Product Code: 97186
Availability: In Stock
Manufacturer: Micro Labs Ltd
Constituents

Telmisartan (40mg) + Cilnidipine (10mg) + Metoprolol (25mg)

Usage of Arbitel-Trio 25 Tablet ER

Arbitel-Trio 25 Tablet ER is used in the treatment of high blood pressure.

Possible Side-effects

Common
  • Nausea
  • Taste change
  • Constipation
  • Diarrhea
  • Headache
  • Dizziness
  • Weakness
  • Ankle swelling
  • Flushing (sense of warmth in the face, ears, neck and trunk)
  • Edema (swelling)
  • Increased potassium level in blood
  • Slow heart rate
  • Numbness of extremity
  • Cold extremities
  • Decreased blood pressure

Unit

1 Strip of 10 Tablet

Manufacturer

Micro Labs Ltd

Disclaimer

Image shown is a representation and may slightly vary from the actual product. Every effort is made to maintain accuracy of all information displayed.

How to use Arbitel-Trio 25 Tablet ER

Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Arbitel-Trio 25 Tablet ER is to be taken with food.

How Medicine Works

Arbitel-Trio 25 Tablet ER is a combination of three medicines: Cilnidipine, metoprolol and telmisartan. They work by different mechanisms to provide better control of blood pressure when single or dual therapy is not effective. Cilnidipine is a calcium channel blocker (CCB) and telmisartan is an angiotensin receptor blocker (ARB). They work by widening and relaxing the blood vessels, thereby lowering blood pressure. Metoprolol is a beta blocker that works specifically on the heart to slow down the heart rate.

Related Warnings

Taking Telmisartan with alcohol may excessively lower the blood pressure.

Arbitel-Trio 25 Tablet ER is unsafe to use during pregnancy.
There is positive evidence of human fetal risk, but the benefits from use in pregnant women may be acceptable despite the risk, for example in life-threatening situations. Please consult your doctor.

No information is available on the use of Arbitel-Trio 25 Tablet ER during lactation. Please consult your doctor.

Arbitel-Trio 25 Tablet ER may make you feel dizzy, sleepy, tired, or decrease alertness. If this happens, do not drive.

There is limited information available on the use of Arbitel-Trio 25 Tablet ER in patients with kidney disease. Please consult your doctor.

Arbitel-Trio 25 Tablet ER should be used with caution in patients with liver disease. Dose adjustment of Arbitel-Trio 25 Tablet ER may be needed. Please consult your doctor.
Use of Arbitel-Trio 25 Tablet ER is not recommended in patients with severe liver disease.

Expert Advice

Frequently Asked Questions (FAQs)

Similar Products

Featured Products